GARS Monoclonal Antibody

$Lane 1: Ramos cell lysates; Lane 2: Jurkat cell lysates; Lane 3: HT-1080 cell lysates probed with GARS Monoclonal Antibody, Unconjugated (bsm-51616M) at 1:4000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.$

Lane 1: Ramos cell lysates; Lane 2: Jurkat cell lysates; Lane 3: HT-1080 cell lysates probed with GARS Monoclonal Antibody, Unconjugated (bsm-51616M) at 1:4000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.

Applications

Predicted Reactivity

Human

Overview
Catalog #	bsm-51616M
Product Name	GARS Monoclonal Antibody
Applications	WB
Predicted Reactivity	Human
Specifications
Conjugation	Unconjugated
Host	Mouse
Source	Recombinant human GARS between 35-305 amino acids.
Clonality	Monoclonal
Clone #	A2S3
Concentration	0.5ug/ul
Storage Buffer	0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage Condition	Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID	2617
Swiss Prot	P41250
Subcellular location	Cytoplasm
Synonyms	AP 4 A synthetase; Charcot Marie Tooth neuropathy 2D; Charcot Marie Tooth neuropathy neuronal type D; CMT2D; Diadenosine tetraphosphate synthetase; DSMAV; EC 6.1.1.14; Glycine tRNA ligase; Glycyl tRNA synthetase; GlyRS; HMN5; SMAD1; GARS_HUMAN.
Background	GARS synthetase catalyzes the ligation of glycine with glycyl-tRNA using ATP and its mutation induces Charcot-Marie-Tooth (CMT) disease.
Application Dilution
WB	=1:500-2000Ôºå

Applications

Predicted Reactivity

Search our catalog of hundreds of thousands of products